BioCatalystWatch
UTHRWorkspace / UTHR / OverviewCompany library
UNITED THERAPEUTICS Corp logo

UNITED THERAPEUTICS Corp

UNITED THERAPEUTICS Corp (UTHR)

Website

Price
Market cap
Next catalystExpected 2H 2026miroliverELAP® · Phase 1 dataCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

Ralinepag Tablets

Prostacyclin IP receptor

PreINDP1P2P3FilingApproved
Upcoming / outlook

Tyvaso

PreINDP1P2P3FilingApproved
Upcoming / outlook

Tyvaso

PreINDP1P2P3FilingApproved
Upcoming / outlook

Approved

PreINDP1P2P3FilingApproved
Upcoming / outlook

miroliverELAP®

PreINDP1P2P3FilingApproved
Upcoming / outlook

Ralinepag DPI

Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

miroliverELAP®

PreINDP1P2P3FilingApproved
Upcoming / outlook

Approved

PreINDP1P2P3FilingApproved
Upcoming / outlook

Tyvaso

PreINDP1P2P3FilingApproved
Upcoming / outlook

Ralinepag Tablets

Prostacyclin IP receptor

PreINDP1P2P3FilingApproved
Upcoming / outlook

Tyvaso

PreINDP1P2P3FilingApproved
Upcoming / outlook

Ralinepag DPI

Upcoming / outlook

Other pipelines

UHeart™

PreINDP2P3FilingApproved
UThymoKidney

UThymoKidney

Treprostinil SMI

PreINDP1P3FilingApproved
miroliver

PreINDP1P2P3FilingApproved
ULobe

PreINDP1P2P3FilingApproved
THY-100

PreINDP1P2P3FilingApproved

Partner / License out

Approved / commercial

Tyvaso

Approved

PreINDP1P2P3FilingApproved
Tyvaso

Approved

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

Approved

PreINDP1P2P3FilingApproved

Approved

PreINDP1P2P3FilingApproved

Approved

PreINDP1P2P3FilingApproved
Upcoming / outlook

Approved

PreINDP1P2P3FilingApproved

GD2

Approved

PreINDP1P2P3FilingApproved

History / paused

Tyvaso

Tyvaso

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

UTHR PR & News

PR & News

UTHR SEC archive